VALENSIN, PIER EGISTO
 Distribuzione geografica
Continente #
NA - Nord America 3.792
EU - Europa 2.774
AS - Asia 508
AF - Africa 13
OC - Oceania 7
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.102
Nazione #
US - Stati Uniti d'America 3.785
GB - Regno Unito 671
IE - Irlanda 574
CN - Cina 403
UA - Ucraina 367
SE - Svezia 335
RU - Federazione Russa 212
DE - Germania 203
FR - Francia 173
FI - Finlandia 107
SG - Singapore 77
IT - Italia 71
ES - Italia 22
BE - Belgio 9
CZ - Repubblica Ceca 9
CA - Canada 7
NL - Olanda 6
AU - Australia 5
CI - Costa d'Avorio 5
JP - Giappone 5
VN - Vietnam 4
BR - Brasile 3
IR - Iran 3
LU - Lussemburgo 3
MW - Malawi 3
EG - Egitto 2
GR - Grecia 2
HK - Hong Kong 2
HU - Ungheria 2
LB - Libano 2
LT - Lituania 2
NZ - Nuova Zelanda 2
SC - Seychelles 2
TR - Turchia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.102
Città #
Southend 587
Fairfield 579
Dublin 568
Chandler 339
Ashburn 318
Jacksonville 294
Woodbridge 276
Menlo Park 252
Wilmington 208
Houston 205
Seattle 198
Cambridge 195
Ann Arbor 162
Princeton 101
Nanjing 97
Beijing 78
New York 61
Singapore 57
Helsinki 48
Boardman 41
Nanchang 38
Shanghai 38
San Diego 31
San Mateo 25
Moscow 24
Málaga 19
Siena 19
Hebei 18
Lancaster 18
Venezia 18
London 17
Munich 17
Tianjin 17
Jiaxing 15
Shenyang 14
Changsha 12
Norwalk 12
Washington 11
Dearborn 10
Kunming 10
Brussels 9
Düsseldorf 8
Redwood City 8
Renton 7
San Francisco 7
Brno 6
Fremont 6
Hangzhou 6
Jinan 6
Zhengzhou 6
Abidjan 5
Changchun 5
Guangzhou 5
Lanzhou 5
Los Angeles 5
Toronto 5
Dallas 4
Falls Church 4
Hanoi 4
Kilburn 4
Ningbo 4
Blantyre 3
Edinburgh 3
Falkenstein 3
Independence 3
Kazan 3
Luxembourg 3
Mestre 3
Prescot 3
Tappahannock 3
University Park 3
Athens 2
Cairo 2
Central 2
Chicago 2
Florence 2
Frankfurt am Main 2
Fuzhou 2
Groningen 2
Guagnano 2
Hendon 2
Hounslow 2
Izmir 2
Loreto 2
Mahé 2
Melbourne 2
Paris 2
Prague 2
Qingdao 2
Saint Petersburg 2
Sydney 2
Taizhou 2
Tashkent 2
Wandsworth 2
Yokkaichi 2
Acton 1
Almaty 1
Amsterdam 1
Atlanta 1
Auburn Hills 1
Totale 5.249
Nome #
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 176
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 173
Serological evidence of reinfection among vaccinees during rubella outbreak 168
The potential role of hepatitis C virus in the pathogenesis of the neurological syndrome in chronic hepatitis C 166
Prevalence of skin allograft discards as a result of serological and molecular microbiological screening in a regional skin bank in Italy 164
Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type 1 nucleoside reverse transcriptase inhibitors 153
Development and significance of the HIV-1 reverse transcriptase M184V mutation during combination therapy with lamivudine, zidovudine and protease inhibitors 151
Fast duplex one-step RT-PCR for rapid differential diagnosis of entero- or toscana virus meningitis 151
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 148
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 148
Detection of genotypically drug-resistant HIV-1 variants and non-B subtypes in recently infected antiretroviral-naive adults in Italy. 147
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 145
Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 142
Microfilament and microtubule alterations in cultured CHO cells during methyl mercury intoxication and protection with selenite 140
Zidovudine resistance mutations and human immunodeficiency virus type 1 DNA burden: longitudinal evaluation of six patients under treatment 139
Analysis of the HIV-1 nef gene in five intravenous drug users with long-term nonprogressive HIV-1 infection in Italy. 138
Tumour associated antigen (TAA) specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes 135
Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8 coinfected patients 135
Nested polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in clinical specimens. 134
Biotechnology for virus vaccine design, production, and control 133
Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice. 133
Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. 132
Helicobacter pylori infection and infertility 130
Concordance between polymerase chain reaction and antibody detection in the diagnosis of human immunodeficiency virus type 1 infection. 128
Long-read direct infrared sequencing of crude PCR products for prediction of resistance to HIV-1 reverse transcriptase and protease inhibitors. 128
Low human immunodeficiency virus titer and polymerase chain reaction false-negatives 124
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples 124
Synthetic peptides of rubella E1 glycoprotein for serological assays 122
Hepatitis C virus infection and myositis: a polymerase chain reaction study 122
Increased reliability of 'selective PCR' using additionally mutated primers and a commercial 'Taq DNA polymerase enhancer' 122
Rapid identification of Toscana virus by nested PCR during an outbreak in the Siena area of Italy 120
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein 116
Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice 115
Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype 114
Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine 113
Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers 111
Identification of Mycobacterium tuberculosis complex, Mycobacterium avium and Mycobacterium intracellulare by selective nested polymerase chain reaction 109
Evaluation of cell-free and cell-associated peripheral blood HIV-1 RNA response to antiretroviral therapy 103
Lack of efficacy of ozone therapy in HIV infection 102
Human immunodeficiency virus-1 infection, homosexuality, and Kaposi-associated herpes-like DNA in peripheral blood mononuclear cells 101
Expression of recombinant E2 and C proteins of rubella virus in insect cells 97
Clinical evaluation of an in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 plasma RNA. 96
Serological evidence of reinfection among vaccinees during rubella outbreak 96
Divergent distribution of HIV-1 drug-resistant variants on and off antiretroviral therapy 95
NMR investigation of cell cultures: early detection of infection by Herpes simplex virus type 2 and transformation 93
Recurrent septicemia in an immunocompromised patient due to probiotic strains of Bacillus subtilis 91
Rapid detection and typing of circulating mumps virus by reverse transcription/polymerase chain reaction 91
Live-cell immunofluorescence for detection of human immunodeficiency virus type 1 (HIV-1)-related antigens in peripheral blood mononuclear cells from HIV-1-seropositive individuals 90
Streptococcus gordonii as a live vaccine vector [Lo Streptococcus gordonii come vettore di vaccini ricombinanti] 90
Comparative evaluation of three computerized algorithms for prediction of antiretroviral susceptibility from human immunodeficiency virus type 1 genotype 87
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 84
Ultrasensitive in-house reverse transcription-competitive PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma 83
Low human immunodeficiency virus type 1 (HIV-1)DNA burden as a major cause for failure to detect HIV-1 DNA in clinical specimens by PCR 82
Viral childhood gastroenteritis 82
Evaluation of the specific immune response after anti-rubella vaccination [Valutazione della risposta immunitaria specifica dopo vaccinazione anti-rosolia] 81
Comparison of M-MLV reverse transcriptase and Tth polymerase activity in RT-PCR of samples with low virus burden 77
Expression of measles virus antigens in Streptococcus gordonii 76
CD4+/CD45RA+ “naive” T cells and immunological response to influenza virus vaccine in B-cell chromnic lymphocitic leukemia patients 73
Simultaneous amplification of multiple human immunodeficiency virus type 1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction 71
Rubella epidemiology over a 14-year period in Siena (Italy): a retrospective serological survey 69
Binding properties of monoclonal antibodies to rabies virus 69
Polymerase chain reaction for detection of human immunodeficiency virus type 1 DNA in peripheral lymphocytes. Results in subjects with high risk of HIV infection 2
Totale 7.130
Categoria #
all - tutte 22.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020886 0 0 0 0 89 93 142 190 128 117 30 97
2020/2021987 50 191 18 97 33 136 25 155 127 42 74 39
2021/2022655 40 83 27 61 58 10 41 21 35 86 45 148
2022/20231.180 71 106 160 176 106 248 10 105 98 29 41 30
2023/2024856 24 20 99 54 28 285 285 15 3 5 1 37
2024/2025342 37 81 135 62 27 0 0 0 0 0 0 0
Totale 7.130